Biocompatible Materials

Published by: Global Industry Analysts

Published: Feb. 1, 2007 - 414 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definition and Scope of Study

Polymeric Materials

Metallic Materials

Natural Materials

Other Materials

II. EXECUTIVE SUMMARY

1. Industry Overview

R&D Creating Brighter Avenues

Current and Future Analysis

Regional Perspective

Segment Wise Perspective

Factors Determining Market Growth

Awareness of Basic Mechanisms of Cell-Material Interaction

Birth of Cross-Disciplinary Field of Tissue Engineering

Rise in Biomaterial Prices

Stem-Cell Technology - A Threat

2. Product Overview

Biocompatible Materials - An Introduction

Definition of Biocompatible Materials

Applications

Orthopedic Applications

Cardiovascular Applications

Dental Applications

Biomaterials as Skin Replacements

Biomaterials as Scaffolds for Tissue Engineering

Product Segments

Polymeric Materials

Hydrogels

Biodegradable Polymers

Metallic Materials

Natural Materials

Collagen

Hyaluronic Acid

Other Materials

Ceramics

Bioactive Ceramics

Applications

Bone Substitutes

Articulating Surfaces in Joint Implants

Composites

Pyloritic Carbon

Biomaterial Segments and Applications: An Outline

3. Product Trends

Biomaterials Play Crucial Role in Implants Market

Natural Substances find Increasing Application in Biomaterial Syntheses

Plastic Companies Join the Fray as Manufacturers of Biodegradable Materials

Ceramic Fillings as Substitute for Silver-Tin-Mercury Amalgam Fillings

Ceramics Offer Significant Potential in Crown Syntheses

Hafnium - A Promising Material for Biocompatible Coatings

Chitin as a New Biomaterial

Bioglass - A Potential Material for Bone Regeneration

Collagen - An Efficient Biomaterial for Synthetic Vascular Grafts

Biopolymers as Biomaterials

Bioabsorbable Intelligent Materials

Biocompatible Coatings - A Boon for Medical Implant Applications

Nanotechnology - Revolutionizes Development of Biomaterial Implants

4. End-Use Market Analysis

Biosensors

Implants

Common Orthopedic Implants: Merits and Demerits

Biocompatibility of Material Implants with Blood

Integrating Heparin to Polymeric Surface

Dental Implants

Crown and Bridge Consumption

Table 1: Worldwide Dental Implant Market (2005): Percentage Share Breakdown for Nobel Biocare, Straumann, Biomet/3i, Sulzer Dental, Dentsply/ Friadent and Others (includes corresponding Graph/Chart)

Joint Implant

Artificial Organs

Artificial Heart

Totally Implantable Artificial Heart (TAH) System

Pneumatic Total Artificial Heart (PTAH)

Cardiopulmonary Bypass System for Long-term Use

Ventricular Assist Device

Artificial Blood Vessels

Artificial Blood

Artificial Skin

Surface Coatings

Materials for Drug Delivery Systems

Polyethylene Glycol as a Drug Delivery System

Hydrogels as Drug Delivery System

Vinylic based Drug Delivery Systems

Collagen Based Drug Delivery System

Electrodes

Tissue Replacement Materials

Dialysis/Separation/Filtration Systems

Dialysis

Filtration and Separation

Cosmetic and Dental Materials

Biomaterials for Cosmetic Formulations

5. Research and Development

Biocompatible Materials - Key Research Objectives

R&D Activity

French Inventors Develop Three-Dimensional Filet Stitch Fabric Wall Reinforcement

California Inventor Develops Biocompatible Material

Scientists Develop Process for Producing Biocompatible Fibers

Penn State Researchers Develop New Niobium Molding Process

Doxa Commences Clinical Trials for Novel Biomaterial

FzioMed Concludes Preliminary Study for Oxiplex Gel

MIV’s Biomaterial Stent Coating Clears Pyrogen Clinical Testing

Novel Biomaterial Coated Coil for Brain Aneurysms Surgery

Researchers Develop Bone Growth Stimulating Material

Scientist Develop Biocompatible Polymers with Optical Properties

Japanese Scientists Develop Novel Bioabsorable Material

Biomaterial Glue as a Substitute for Staples

Scientist Develop Biocompatible Intraocular (IOL) Lens

New Biodegradable Plastic with “Shape Memory”

Biorubber - An Elastic Polymer for Tissue Engineering Applications

Orthovita Concludes Trials for Artificial Bone Material

Teijin Develops Novel Biomaterial

Synthesis of Porous Coatings for Enhanced Implant Life

Capsular Tension Ring Finds Place in Cataract Surgery

Porous Silicon Found to be Biocompatible

Silicone and Acrylic IOLs Equally Biocompatible

Use of In-Vitro Methods to Reduce Extent of Animal Testing

Implantation of Materials Resulting in Undesirable Local and Systemic Reactions

Novel Biocompatible Materials

Development of Bioactive Organic-Inorganic Hybrids

Providing Metallic Implants with Bioactivity by Surface

Modification

Compositional Dependence of Bioactivity of Ceramic Materials

Biocompatible Polymers with Optical Properties of Silicon Sensors

Biocompatible Polyester Based Polymer Alloys Derived from Natural Resources

New Technology for Coating Medical Devices and Implants

Polyhydroxyalkanoate-RD - A New Class of Biopolymers

Vapor Technologies' Patented LTAVD

Microchannel Arrays for Artificial Lungs

Bone Biomaterial - A Novel Bioactive Technology for Bone Reconstruction

Biomaterial Adhesives for Restoring Vascular Tissues

Researchers Develop Microspheres for Bone Tissue Engineering and Regeneration

Researchers Develop Glycol Hydrogel

Researchers Develop Biomaterial for Generating Mammalian Nerve Cells

Cornell University Develops Jelly-Like Hydrogels

6. Regulatory Environment

FDA Regulations

American Society for Testing and Materials (ASTM)

Joint Research Center (JRC)

Biocompatibility Testing of Materials

Testing Levels

General Biocompatibility Testing

Individual Biocompatibility Testing

Testing Methods

7. Product Introductions/Innovations

Invibio® Launches ENDOLIGN™ Polymer Composite

Zimmer Dental Launches the Puros® Dermis Allograft Tissue Matrix

Integra Launches Nerve Injury Products

DePuy Mitek Expands Orthopedics Product Portfolio

DSM Dyneema Introduces Polyethylene Fiber

Product Introductions/Innovations in Recent Past

Wright Medical Unveils Artificial Bone

Orthovita Rolls Out ALIQUOT Microdelivery System

Cohesion Technologies Introduces CoSeal(R)

Thermoelastic Technologies Offers BITEM

STS Biopolymers Develops Polymer Coating

Biocoat Launches Hydak Coatings

BioDelivery Debuts Celltran

Gore Launches Gore-Tex Dualmesh(R) Biomaterial

STS Biopolymer Introduces Echo-coat Ultrasound Needle

STS Biopolymer Develops Graft-Coat

Spire Develops Hydroxyapatite Coating

Artimplant Creates Biodegradable Implant

Encoll Develops Proprietary Technology for Bovine Collagen

Biosyntech Develops Cargel

Tissuemed Develops Tissuebond

Confluent Surgical Creates Sprayable Biocompatible Hydrogels

Victrex Develops PEEK Optima LT

Cook Debuts Biomaterial for Veterinary Use

Invotec Offers New Antibacterial Nasal Packing

Kurz Debuts Titanium Middle Ear Prostheses

Polymer Technology Group Launches Biocompatible Polyurethanes

8. Recent Industry Activity

Tyco International To Acquire Confluent Surgical

SurModics Acquires Intralytix’s Biodegradable Polymer Technology

Orthovita Signs a Collaboration Agreement with Aastrom Biosciences for Orthopedic Products

Kuhnil Pharma Acquires Rights from BioSyntech

SurModics Licenses Hydrophilic Coating to Devax

BioSyntech Receives Notice of Allowance from the US Patent and Trademark Office for BST-CarGel®

Artimplant Signs License and Development Agreements with Small Bone Innovations

SaluMedica Licenses Proprietary Biomaterial to Spine Medica

SurModics Licenses Hydrophilic Technology to Medtronic

SurModics Obtains Exclusive Rights from Rutgers University to Biodegradable Polymers for Ophthalmology

MIV Therapeutics Inks Research Agreement with University of British Columbia

Zimmer Acquires Implex

Biomet Acquires Interpore

Angiotech Acquires NeuColl

Synthes-Stratec Inc. and Mathys Medizinaltechnik AG Merge

Kyocera and Kobe Steel Forms a Joint Venture

Angiotech Expands Biomaterial Licensing Agreement with Poly-Med

Genzyme Corp Enters into Agreement with Wyeth Pharmaceuticals

OctoPlus Grants License to SurModics to Acquire Two Novel Biodegradable Polymers

GP Surgical Receives FDA Approval for TiMESH

Industry Activity in Recent Past

Angiotech Acquires STS Biopolymers

Angiotech Acquires Cohesion Technologies

Life Medical Takes Over Polymer Technology Assets of Phairson

IsoTis Merges with GenSci

Wright Medical Receives FDA Approval for COC Hip Replacement System

Encore Obtains FDA Approval for COC Hips

Haemacure Obtains US Patent for Fibrin-Based Biocompatible Material

Life Medical Obtains US Patent for Polymeric Biomaterials

pSivida’s Subsidiary Joins Hands with University of Nottingham

Medtronic and Abbott Enter into Partnership

Neomend obtains U.S. Patent for Barrier Biomaterial and Vascular Sealant

Orthovita Receives Patent for Proprietary Biomaterials Platform

Synthes-Stratec Obtains Approval for Increased Usage of Norian SRS®

Interpore Acquires AOM

CardioTech and ISC Enter into Collaboration

MacroMed Inks Multi-Drug Evaluation and Option Agreement with BMS

Salumedica Receives Patent for Platform Technology

GenSci Receives Patent for DynaGraft(TM) and OrthoBlast(TM)

Anika Obtains FDA Approval for Ophthalmic Product

S&N and ATS Obtain Pre-Market Approval for Dermagraft Synthetic Skin

ThermoElastic Technologies Signs Agreement with Zahn Dental

Collagenesis Obtains Patent for Tissue Collagen Matrix Production Method

STAAR Gets FDA Approval for Collamer IOL

9. Focus on Select Global Players

Angiotech Pharmaceuticals Inc. (Canada)

Artimplant (Sweden)

A.P. Pharma, Inc. (USA)

AST Products, Inc. (USA)

Biocoat, Inc. (USA)

BIOSYNTECH (Canada)

DENTSPLY International Inc. (USA)

Invibio (UK)

Integra LifeSciences Holdings Corporation (USA)

Orthovita (USA)

SaluMedica, LLC (USA)

SurModics (USA)

Syneture (USA)

Synthes-Stratec, Inc (USA)

10. Global Market Perspective

Table 2: World Recent Past, Current and Future Analysis for Biocompatible Materials by Geographic Region - North America, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 3: World 11-Year Perspective for Biocompatible Materials by Geographic Region - Percentage Breakdown of Dollar Sales for North America, Japan, Europe, and Rest of World Markets for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Table 4: World Recent Past, Current and Future Analysis for Polymeric Materials by Geographic Region - North America, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 5: World 11-Year Perspective for Polymeric Materials by Geographic Region - Percentage Breakdown of Dollar Sales for North America, Japan, Europe, and Rest of World Markets for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Table 6: World Recent Past, Current and Future Analysis for Metallic Materials by Geographic Region - North America, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 7: World 11-Year Perspective for Metallic Materials by Geographic Region - Percentage Breakdown of Dollar Sales for North America, Japan, Europe, and Rest of World Markets for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Table 8: World Recent Past, Current and Future Analysis for Natural Materials by Geographic Region - North America, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 9: World 11-Year Perspective for Natural Materials by Geographic Region - Percentage Breakdown of Dollar Sales for North America, Japan, Europe, and Rest of World Markets for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

Table 10: World Recent Past, Current and Future Analysis for Other Materials by Geographic Region - North America, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 11: World 11-Year Perspective for Other Materials by Geographic Region - Percentage Breakdown of Dollar Sales for North America, Japan, Europe, and Rest of World Markets for Years 2000, 2006 and 2010(includes corresponding Graph/Chart)

III. MARKET

1. North America

A. Market Analysis

Outlook

Regulatory Environment

FDA Regulations

American Society for Testing and Materials (ASTM)

R&D Activity

Potential Biomaterial Shortage

Effects of Potential Shortages

Product Introductions/ Innovations in Recent Past

Strategic Developments

Industry Activity in Recent Past

Review of Select Players

B. Market Analytics

Table 12: North American Recent Past, Current and Future Analysis for Biocompatible Materials by Product Segment - Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 13: North American 11-Year Perspective for Biocompatible Materials by Product Segment - Percentage Breakdown of Dollar Sales for Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets for 2000, 2006 and 2010 (includes corresponding Graph/Chart)

2. Japan

A. Market Analysis

Outlook

An Overview

Import Scenario: Implants

Table 14: Japanese Percentage Imports by Implant Type (includes corresponding Graph/Chart)

History

Major Biomaterial Research Groups

Institute of Biomedical Engineering (Tokyo Women’s Medical University)

Tissue Engineering Research Institute (Kyoto University)

Institute of Biomaterials and Bioengineering (Tokyo Medical and Dental University)

Principal Research Institutions

R&D in the Recent Past

Regulatory Environment

Medical Affairs Law

Strategic Development

B. Market Analytics

Table 15: Japanese Recent Past, Current and Future Analysis for Biocompatible Materials by Product Segment - Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 16: Japanese 11-Year Perspective for Biocompatible Materials by Product Segment - Percentage Breakdown of Dollar Sales for Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets for 2000,2006 and 2010 (includes corresponding Graph/Chart)

3. Europe

A. Market Analysis

Outlook

UK Bioceramic Market

R&D Activity in the Recent Past

Regulatory Environment

Government Regulations

Joint Research Center (JRC)

Product Introductions/Innovations

Product Introductions/Innovations in Recent Past

Strategic Developments

Review of Select Players

B. Market Analytics

Table 17: European Recent Past, Current and Future Analysis for Biocompatible Materials by Product Segment - Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)

Table 18: European 11-Year Perspective for Biocompatible Materials by Product Segment - Percentage Breakdown of Dollar Sales for Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets for Years 2000, 2006 and 2010 (includes corresponding Graph/Chart)

4. Rest of World

A. Market Analysis

Outlook

Strategic Development

B. Market Analytics

Table 19: Rest of World Recent Past, Current and Future Analysis for Biocompatible Materials by Product Segment - Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart)

Table 20: Rest of World 11-Year Perspective for Biocompatible Materials by Product Segment - Percentage Breakdown of Dollar Sales for Polymeric Materials, Metallic Materials, Natural Materials and Other Materials Markets for 2000, 2006 and 2010 (includes corresponding Graph/Chart)

IV. COMPETITION

1. 3DM, Inc. (USA)

2. AP Pharma, Inc. (USA)

Table 21: Annual Sales Analysis: 2004-2005 (In US$ thousands)

Table 22: Annual Sales Analysis by Quarter: 2004-2005 (In US$ thousands)

3. Aastrom Biosciences, Inc. (USA)

Table 23: First Quarter Sales Analysis: 2006-2007 (In US$ thousands)

Table 24: Annual Sales Analysis: 2005-2006 (In US$ thousands)

Table 25: Annual Sales Analysis by Quarter: 2005-2006 (In US$ thousands)

4. Absorbable Polymers International (USA)

5. Alkermes, Inc. (USA)

Table 26: Half Yearly Sales Analysis: 2006-2007 (H1) (In US$ million)

Table 27: Half Yearly Sales Analysis by Quarter: 2006-2007 (H1) (In US$ million)

Table 28: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 29: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

6. Allergan, Inc. (USA)

Table 30: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 31: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 32: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 33: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 34: Annual Sales Analysis by Product: 2004-2005 (In US$ million)

Table 35: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Inamed Corporation (USA)

7. Alloys International, Inc. (USA)

8. Angiotech Pharmaceuticals, Inc. (Canada)

Table 36: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 37: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 38: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 39: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

9. Anika Therapeutics, Inc. (USA)

Table 40: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 41: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 42: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 43: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 44: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

10. Apex Medical Technologies, Inc. (USA)

11. Artes Medical, Inc. (USA)

12. Artimplant AB (Sweden)

Table 45: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In SEK million)

Table 46: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In SEK million)

Table 47: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In SEK million)

Table 48: Annual Sales Analysis: 2004-2005 (In SEK million)

Table 49: Annual Sales Analysis by Geographic Region: 2004-2005 (In SEK million)

13. AST Products, Inc. (USA)

14. Astro Seal, Inc. (USA)

15. BASF AG (Germany)

Table 50: First Quarter Sales Analysis: 2005-2006 (In € billion)

Table 51: First Quarter Sales Analysis by Segment: 2005-2006 (In € billion)

Table 52: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In € billion)

Table 53: Annual Sales Analysis: 2004-2005 (In € billion)

16. Biochrom Labs, Inc. (USA)

17. Biocoat, Inc. (USA)

18. Biocompatibles International PLC (UK)

Table 54: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million)

Table 55: Annual Sales Analysis: 2004-2005 (In £ million)

19. BioInteractions Ltd. (UK)

20. Biomet, Inc. (USA)

Table 56: First Quarter Sales Analysis: 2006-2007 (In US$ million)

Table 57: First Quarter Sales Analysis by Segment: 2006-2007 (In US$ million)

Table 58: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 59: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 60: Annual Sales Analysis by Segment:

2005-2006 (In US$ million)

Table 61: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Biomet Europe (The Netherlands)

Biomet UK Limited (UK)

21. BioSyntech, Inc. (Canada)

Table 62: First Quarter Sales Analysis: 2005-2006 (In Can$ thousands)

Table 63: Annual Sales Analysis: 2004-2005 (In Can$ thousands)

Table 64: Annual Sales Analysis by Geographic Region: 2004-2005 (In Can$ thousands)

22. C. R. Bard, Inc. (USA)

Table 65: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 66: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 67: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 68: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Table 69: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

23. Carmeda AB (Sweden)

Carmeda, Inc. (USA)

24. ColBar Lifescience Ltd. (Israel)

25. Collagen Matrix, Inc. (USA)

26. Confluent Surgical, Inc. (USA)

27. Degradable Solutions AG (Switzerland)

28. Dentsply International, Inc. (USA)

Table 70: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 71: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 72: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 73: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 74: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 75: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Dentsply Friadent CeraMed (USA)

29. DSM Dyneema (The Netherlands)

30. EMPA (Switzerland)

31. FibroGen, Inc. (USA)

FibroGen Europe Corporation (Finland)

32. FMC Corporation (USA)

Table 76: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 77: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 78: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 79: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 80: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 81: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

FMC BioPolymer (USA)

33. FzioMed, Inc. (USA)

34. Geistlich Group (Switzerland)

35. Gel-Del Technologies, Inc. (USA)

36. Genzyme Corporation (USA)

Table 82: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 83: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 84: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 85: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 86: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 87: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Genzyme Biosurgery (USA)

37. Hydromer, Inc. (USA)

Table 88: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 89: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

38. Imedex Biomatériaux (France)

39. Integra Lifesciences Holdings Corporation (USA)

Table 90: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 91: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 92: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 93: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 94: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 95: Annual Sales Analysis by Product: 2004-2005 (In US$ million)

40. Invibio Ltd. (UK)

41. IsoTis Orthobiologics (Switzerland)

42. Johnson & Johnson (USA)

Table 96: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 97: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 98: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 99: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 100: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 101: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 102: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million)

Table 103: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

DePuy Mitek, Inc. (USA)

43. Kensey Nash Corporation (USA)

Table 104: First Quarter Sales Analysis: 2006-2007 (In US$ million)

Table 105: First Quarter Sales Analysis by Segment: 2006-2007 (In US$ million)

Table 106: First Quarter Sales Analysis by Geographic Region: 2006-2007 (In US$ million)

Table 107: Ann

ual Sales Analysis: 2004-2006 (In US$ million)

Table 108: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 109: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 110: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 111: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 112: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

Table 113: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Kensey Nash Europe GmbH (Germany)

44. Lifecore Biomedical, Inc. (USA)

Table 114: Half Yearly Sales Analysis: 2006-2007 (H1) (In US$ million)

Table 115: Half Yearly Sales Analysis by Quarter: 2006-2007 (H1) (In US$ million)

Table 116: Half Yearly Sales Analysis by Segment: 2006-2007 (H1) (In US$ million)

Table 117: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 118: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 119: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 120: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

45. Matricel GmbH (Germany)

46. Medtronic, Inc. (USA)

Table 121: Annual Sales Analysis: 2004-2006 (In US$ billion)

Table 122: Annual Sales Analysis by Quarter: 2005-2006 (In US$ billion)

Table 123: Annual Sales Analysis by Segment: 2005-2006 (In US$ billion)

Table 124: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ billion)

Table 125: Annual Sales Analysis by Quarter: 2004-2005 (In US$ billion)

Table 126: Annual Sales Analysis by Segment: 2004-2005 (In US$ billion)

Table 127: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion)

47. Mentor Corporation (USA)

Table 128: Half Yearly Sales Analysis by Quarter: 2006-2007 (H1) (In US$ million)

Table 129: Half Yearly Sales Analysis by Product: 2006-2007 (H1) (In US$ million)

Table 130: Annual Sales Analysis: 2005-2006 (In US$ million)

Table 131: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 132: Annual Sales Analysis by Product: 2005-2006 (In US$ million)

Table 133: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million)

Table 134: Annual Sales Analysis by Product: 2004-2005 (In US$ million)

Table 135: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

48. MIV Therapeutics, Inc. (Canada)

49. Nobel Biocare Holding AG (Switzerland)

Table 136: Annual Sales Analysis: 2004-2005 (In € million)

Table 137: Annual Sales Analysis by Geographic Region: 2004-2005 (In € million)

50. NOF Corporation (Japan)

Table 138: Annual Sales Analysis: 2004-2005 (In ¥ million)

Table 139: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million)

Table 140: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million)

51. Organogenesis, Inc. (USA)

52. Ortec International, Inc. (USA)

53. Orthovita, Inc. (USA)

Table 141: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 142: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 143: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 144: Quarterly Sales Analysis: 2004-2005 (In US$ million)

Table 145: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

54. Porex Surgical, Inc. (USA)

55. QLT, Inc. (Canada)

Table 146: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 147: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 148: Nine Months Sales Analysis by Product: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 149: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

56. Q-Med AB (Sweden)

57. Rutgers, The State University of New Jersey (USA)

58. SaluMedica LLC (USA)

59. Small Bone Innovations, Inc. (USA)

60. Solvay Advanced Polymers LLC (USA)

61. SurModics, Inc. (USA)

Table 150: Annual Sales Analysis: 2004-2006 (In US$ million)

Table 151: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million)

Table 152: Annual Sales Analysis by Segment: 2005-2006 (In US$ million)

Table 153: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 154: Annual Sales Analysis by Segment: 2004-2005 (In US$ million)

62. Tepha, Inc. (USA)

63. Terumo Corporation (Japan)

Table 155: Annual Sales Analysis: 2004-2006 (In ¥ billion)

Table 156: Annual Sales Analysis by Segment: 2005-2006 (In ¥ billion)

Table 157: Annual Sales Analysis by Geographic Region: 2005-2006 (In ¥ billion)

Table 158: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion)

Table 159: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion)

64. The Polymer Technology Group, Inc. (USA)

65. United States Surgical - Syneture (USA)

66. University Of British Colombia (USA)

Table 160: Annual Sales Analysis: 2005-2006 (In Can$ million)

67. Vivoxid Ltd. (Finland)

68. W. L. Gore & Associates, Inc. - Medical Products Division (USA)

69. Wright Medical Technology, Inc. (USA)

Table 161: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 162: Nine Months Sales Analysis by Product: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 163: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 164: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 165: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 166: Annual Sales Analysis by Product: 2004-2005 (In US$ million)

Table 167: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

70. Zimmer Holdings, Inc. / Zimmer, Inc. (USA)

Table 168: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 169: Nine Months Sales Analysis by Product: 2005-2006 (Nine Months Ended, September) (In US$ million)

Table 170: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) ( In US$ million)

Table 171: Annual Sales Analysis: 2004-2005 (In US$ million)

Table 172: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million)

Table 173: Annual Sales Analysis by Product: 2004-2005 (In US$ million)

Table 174: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million)

Abstract

This report analyzes the worldwide markets for Biocompatible Materials in Millions of US$. The specific product segments analyzed are Polymeric Materials, Metallic Materials, Natural Materials, and Other Materials. The report provides separate comprehensive analytics for the North America, Japan, Europe, and Rest of World. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 70 companies including many key and niche players worldwide such as Angiotech Pharmaceuticals Inc., Artimplant, A.P. Pharma, Inc., AST Products, Inc., Biocoat, Inc., BIOSYNTECH, DENTSPLY International Inc., Invibio, Integra LifeSciences Holdings Corporation,. Orthovita, SaluMedica, LLC, SurModics, Syneture, and Synthes-Stratec, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies (when hard copy is available)is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location. Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your personal library immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.